(Q51750458)

English

MicroRNA-21 is a unique signature associated with coronary plaque instability in humans by regulating matrix metalloproteinase-9 via reversion-inducing cysteine-rich protein with Kazal motifs.

scientific article published in March 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 April 2018

http://europepmc.org/abstract/MED/24594117

MicroRNA-21 is a unique signature associated with coronary plaque instability in humans by regulating matrix metalloproteinase-9 via reversion-inducing cysteine-rich protein with Kazal motifs. (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 April 2018

http://europepmc.org/abstract/MED/24594117

1 reference

based on heuristic

inferred from title

author name string

Xuesong Fan

1

1 reference

Europe PubMed Central

PubMed publication ID

11 April 2018

http://europepmc.org/abstract/MED/24594117

Enshi Wang

2

1 reference

Europe PubMed Central

PubMed publication ID

11 April 2018

http://europepmc.org/abstract/MED/24594117

Xianyun Wang

3

1 reference

Europe PubMed Central

PubMed publication ID

11 April 2018

http://europepmc.org/abstract/MED/24594117

Xiangfeng Cong

4

1 reference

Europe PubMed Central

PubMed publication ID

11 April 2018

http://europepmc.org/abstract/MED/24594117

Xi Chen

5

1 reference

Europe PubMed Central

PubMed publication ID

11 April 2018

http://europepmc.org/abstract/MED/24594117

publication date

1 March 2014

1 reference

Europe PubMed Central

PubMed publication ID

11 April 2018

http://europepmc.org/abstract/MED/24594117

Experimental and Molecular Pathology

1 reference

Europe PubMed Central

PubMed publication ID

11 April 2018

http://europepmc.org/abstract/MED/24594117

96

1 reference

Europe PubMed Central

PubMed publication ID

11 April 2018

http://europepmc.org/abstract/MED/24594117

2

1 reference

Europe PubMed Central

PubMed publication ID

11 April 2018

http://europepmc.org/abstract/MED/24594117

242-249

1 reference

Europe PubMed Central

PubMed publication ID

11 April 2018

http://europepmc.org/abstract/MED/24594117

The functions of animal microRNAs

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.02.009

7 January 2021

Human neutrophils uniquely release TIMP-free MMP-9 to provide a potent catalytic stimulator of angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.02.009

7 January 2021

MicroRNAs: genomics, biogenesis, mechanism, and function

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.02.009

7 January 2021

Soluble Jagged-1 inhibits neointima formation by attenuating Notch-Herp2 signaling

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.02.009

7 January 2021

TIMP3 is reduced in atherosclerotic plaques from subjects with type 2 diabetes and increased by SirT1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.02.009

7 January 2021

Role of microRNAs in plant and animal development

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.02.009

7 January 2021

Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.02.009

7 January 2021

Concept of vulnerable/unstable plaque

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.02.009

7 January 2021

MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.02.009

7 January 2021

Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.02.009

7 January 2021

MicroRNA-21 expression is regulated by β-catenin/STAT3 pathway and promotes glioma cell invasion by direct targeting RECK.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.02.009

7 January 2021

The immune system in atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.02.009

7 January 2021

MicroRNA profiling identifies miR-34a and miR-21 and their target genes JAG1 and WNT1 in the coordinate regulation of dendritic cell differentiation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.02.009

7 January 2021

The peripheral blood mononuclear cell microRNA signature of coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.02.009

7 January 2021

MicroRNAs in cell proliferation, cell death, and tumorigenesis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.02.009

7 January 2021

MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.02.009

7 January 2021

Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR).

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.02.009

7 January 2021

Progress and challenges in translating the biology of atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.02.009

7 January 2021

MicroRNA-21 acts as an oncomir through multiple targets in human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.02.009

7 January 2021

Circulating microRNAs as stable blood-based markers for cancer detection

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.02.009

7 January 2021

New opportunities for identification and reduction of coronary risk: treatment of vulnerable patients, arteries, and plaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.02.009

7 January 2021

Histopathologic characteristics of atherosclerotic coronary disease and implications of the findings for the invasive and noninvasive detection of vulnerable plaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.02.009

7 January 2021

Natural human monocyte gelatinase and its inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.02.009

7 January 2021

miR-21, miR-210, miR-34a, and miR-146a/b are up-regulated in human atherosclerotic plaques in the Tampere Vascular Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.02.009

7 January 2021

MicroRNAs in the atherosclerotic plaque

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.02.009

7 January 2021

Deciphering the transcriptional circuitry of microRNA genes expressed during human monocytic differentiation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.02.009

7 January 2021

MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.02.009

7 January 2021

M-RIP targets myosin phosphatase to stress fibers to regulate myosin light chain phosphorylation in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.02.009

7 January 2021

Three matrix metalloproteinases are required in vivo for macrophage migration during embryonic development.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.02.009

7 January 2021

Serum microRNA-21 and microRNA-221 as potential biomarkers for cerebrovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.02.009

7 January 2021

Polycyclic aromatic hydrocarbons inhibit differentiation of human monocytes into macrophages

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.02.009

7 January 2021

MiR-21 is induced in endothelial cells by shear stress and modulates apoptosis and eNOS activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.02.009

7 January 2021

Neutral metalloproteinases produced by human mononuclear phagocytes. Enzyme profile, regulation, and expression during cellular development

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2014.02.009

7 January 2021

Identifiers

10.1016/J.YEXMP.2014.02.009

1 reference

Europe PubMed Central

PubMed publication ID

11 April 2018

http://europepmc.org/abstract/MED/24594117

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 April 2018

http://europepmc.org/abstract/MED/24594117

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51750458&oldid=1370695784"